Objectives: Recent genome-wide association studies (GWASs) have identified numerous putative genetic polymorphisms associated with bipolar disorder (BD) and/or schizophrenia (SC). We hypothesized that a portion of these polymorphisms would also be associated with BD in the Latino American population. To identify such regions, we tested previously identified genetic variants associated with BD and/or SC and ancestral haploblocks containing these single nucleotide polymorphisms (SNPs) in a sample of Latino subjects with BD.
| INTRODUCTION
The genetic contribution to psychiatric illnesses such as bipolar disorder (BD) and schizophrenia (SC) have been difficult to define due to issues of clinical heterogeneity, phenotypic overlap and lack of a simple mode of inheritance. These disorders are thought to be influenced by several genes as well as environmental factors. Family, twin, and adoption studies in BD have shown that there is a substantial genetic component [for review, see 1 ]. BD has one of the highest heritability rates of all known psychiatric disorders, with estimates ranging from 85% to 93%. 2, 3 In addition, several studies have reported evidence of familial co-aggregation or comorbidity between BD and SC, mainly attributable to overlapping genetic influences. 4 Over the past several years, genome-wide association studies (GWASs) have identified genetic variants that contribute to complex human disorders or physiological traits. 5 To date, over 10 000 putative single nucleotide polymorphism ).
GWAS results reported to date are based almost exclusively on extensive cohorts of European ancestry. 7 It has been argued that the expansion of GWASs to diverse populations is needed in order for populations worldwide to benefit from medical advances resulting from genome science. There are also considerable scientific benefits to be knowledge by attempting to replicate current GWAS findings in a large sample of Latino subjects with BD using a family-based approach.
Family-based association testing of single markers and haplotypes offers several advantages over GWASs. Family-based study designs are robust to the effects of spurious associations caused by population stratification, structure, and admixture. 10 Family-based designs also allow the detection of Mendelian errors, which offers a level of genotyping quality control that cannot be matched by GWASs. Haplotypebased methods also represent a powerful approach to disease gene mapping based on the association between functional variants and the inherited ancestral haplotypes. 11 We assume that some of the affected individuals may have inherited novel mutations from a common ancestor and that these individuals are likely to share alleles at SNPs in strong linkage disequilibrium (LD) with the disease-causing variant. It should therefore be possible to track a variant allele in the population by identifying the particular ancestral segment on which it arose.
We hypothesized that previously identified genetic variants asso- ), had excessive missing genotype data (>5%), or had low minor allele frequency (<1%). Individuals with >5% missing data were also removed from the analysis. All Mendelian errors were set to missing.
| Statistical analyses
Allele 
| RESULTS
Sample distributions of participants with BD based on country of origin are described in Table 1 Table 2 for a descriptive for narrow and broad BD phenotypes (MAF=0.3), respectively ( Fig. 1) .
Of the 91 a priori SNPs selected from the NHGRI Catalog of Published Genome-Wide Association Studies, we were able to replicate associations of eight SNPs with BD in our Latino sample (Table 3,   Supplementary Table S1 ). Of these, three SNPs within the nuclear factor I A (NFIA), lysosomal associated membrane protein 3 (LAMP3), and major histocompatibility complex, class I, B (HLA-B) genes were previously associated with a BD phenotype. 25, 36 One of the replicated SNPs, located within nuclear factor kappa B subunit 1 (NFKB1), was initially reported in an SC GWAS. 
| DISCUSSION
We previously reported haplotype associations with BD in two genes (calcium voltage-gated channel subunit alpha1 C [CACNA1C] and ankyrin 3
[ANK3] involved in calcium signaling, previously found to be associated with psychiatric disease in European populations. 15 We reported a positive association between an eight-locus haplotype in CACNA1C and BD (permuted P=.005; global marker permuted P=.002) 53 and between a sixlocus haplotype block in ANK3 and BD (permuted P=.025; global marker permuted P=.021). 54 The current study was designed to expand on these previous findings by testing additional markers identified through GWASs of both BD and SC in a larger Latino sample. To the best of our knowl- Previous genome-wide association studies (GWASs) indicate the initial citation(s) of the association, clinical phenotype(s), and ancestry populations tested. Minor allele (based on TOP strand), minor allele frequency (MAF), odds ratio (OR), permuted P-value based on 10 000 permutation, and direction of association are listed for replicated a priori GWAS SNPs under narrow (bipolar disorder type I) and broad (bipolar disorder type I/II, schizoaffective bipolar type, or bipolar disorder not otherwise specified) bipolar phenotypes. BD, bipolar disorder; CI, confidence interval; OR, odds ratio; RAF, risk allele frequency; NFIA, nuclear factor I A; SDCCAG8, serologically defined colon cancer antigen 8; MIR6828, microRNA 6828; SLC7A14, solute carrier family 7 member 14; LAMP3, lysosomal associated membrane protein 3; NFKB1, nuclear factor kappa B subunit 1; HLA-B, major histocompatibility complex, class I, B; SHH, sonic hedgehog; LINC01006, long intergenic non-protein coding RNA 01006; NT5C2, 5′-nucleotidase, cytosolic II; SC, schizophrenia; SA, schizoaffective disorder; PGC, Psychiatric Genome-wide Association Study Consortium. Study populations: previously reported to associate with schizophrenia. We are the first to report a cross-disorder association of the rs230529 SNP with BD.
SNP rs6703335, located on chromosome 1:243445665 within SDCCAG8, was one of the markers for which the replicated association was strongest in both narrow (P=6.00E −4 , OR=0.685) and broad (P=4.00E −4 , OR=0.714) BD phenotypes within our Latino population.
Rs6703335 has previously been associated with both BD and SC in both meta-analysis of GWASs 41 and independent GWASs. 28, 49, 55 SDCCAG8 encodes serologically defined colon cancer antigen 8, a centrosome-associated protein. This protein is believed to be involved in organizing the centrosome during interphase and mitosis. While the specific disease variant is yet to be identified, mouse gene knockdown analysis reveals that SDCCAG8 plays a role in the polarity and migration of nascent neurons in the developing cortex.
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The second goal of this project was to identify Latino ancestral haploblocks associated with BD. To this end, we performed a family-based haplotype analysis for 76 genomic regions that had been previously implicated in GWASs. A three-marker haploblock in the LAMP3 gene was suggestively associated with narrow and broad BD phenotypes ( ). Meta-analysis combining SC, schizoaffective disorder, and BD GWAS data has also implicated rs230529 as being associated with a 'broad psychosis' phenotype.
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Our SNP analysis in Latino populations has identified rs230529 and the neighboring SNP rs230535 within NFKB1 as being associated with both a narrow and a broad BD phenotype. These data taken together strongly implicate the NFKB1 gene region in carrying disease-causing variants for SC and BD. Attempts to identify these variants are currently underway.
Our study is not without limitations. First, 706 subjects with BD is a small sample from the standpoint of association analysis (many of the European studies contain thousands of affected subjects). Accurate and sensitive genetic analyses of the Latino population require substantially larger samples in order to identify gene variants that might be specific to this population, as well as to confirm variants known to be associated with BD in other populations. Second, the current study focuses on subjects of Mexican and Central American ancestry only.
Depending on the origin of ancestral haploblocks, our results may or may not be generalizable to other Latino and Hispanic populations.
These results may contribute to understanding of the genetic and neurobiological functioning of BD in the Latino population. The identification of associated variants will provide insight into the perturbation of the biochemical pathways associated with these genes which have been implicated in BD. Future investigations of gene variants identified in these analyses may add to our understanding of the etiology of these disorders and could point to novel diagnostic tools and pharmaceutical treatments for BD within Latino communities. These results also provide additional evidence for overlap in genetic risk between SC and BD, a finding that has now been reported for several gene variants associated with both BD and SC. 23 Future sequencing studies should focus on these disease-associated haplotypes co-segregating in families to identify biologically relevant variants, which may lead to the identification of population/ethnic-specific genetic biomarkers for BD. Lastly, to better identify the genetic contributions to BD in the Latino population, there is a critical need to recruit larger samples of subjects to allow for more robust association studies to be conducted in this important and understudied population.
